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Abstract 
Background: A comprehensive assessment of the epigenetic dynamics in cancer cells is the key to understand‑
ing the molecular mechanisms underlying cancer and to improving cancer diagnostics, prognostics and treat‑
ment. By combining genome‑wide ChIP‑seq epigenomics and microarray transcriptomics, we studied the effects 
of oxygen deprivation and subsequent reoxygenation on histone 3 trimethylation of lysine 4 (H3K4me3) and lysine 
27 (H3K27me3) in a breast cancer cell line, serving as a model for abnormal oxygenation in solid tumors. A priori, 
epigenetic markings and gene expression levels not only are expected to vary greatly between hypoxic and normoxic 
conditions, but also display a large degree of heterogeneity across the cell population. Where traditionally ChIP‑seq 
data are often treated as dichotomous data, the model and experiment here necessitate a quantitative, data‑driven 
analysis of both datasets.
Results: We first identified genomic regions with sustained epigenetic markings, which provided a sample‑specific 
reference enabling quantitative ChIP‑seq data analysis. Sustained H3K27me3 marking was located around cen‑
tromeres and intergenic regions, while sustained H3K4me3 marking is associated with genes involved in RNA binding, 
translation and protein transport and localization. Dynamic marking with both H3K4me3 and H3K27me3 (hypoxia‑
induced bivalency) was found in CpG‑rich regions at loci encoding factors that control developmental processes, 
congruent with observations in embryonic stem cells.
Conclusions: In silico‑identified epigenetically sustained and dynamic genomic regions were confirmed through 
ChIP‑PCR in vitro, and obtained results are corroborated by published data and current insights regarding epigenetic 
regulation.
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Background
Epigenomics explores genome-wide epigenetic modi-
fications, such as DNA (hydroxy)methylation or post-
translational modification of N-terminal histone tails 
[1]; such marking is often dynamic and serves to support 
phenotypic plasticity. Well-known examples of histone 
modifications are trimethylation of histone 3 lysine 4 
(H3K4me3) and lysine 27 (H3K27me3), which are often 
associated with transcriptional activity and repression, 
respectively. Combined chromatin immunoprecipita-
tion (ChIP) and high-throughput sequencing technology 
(ChIP-seq [2, 3]) has proven to be a powerful approach to 
create genome-wide maps of such histone modifications 
in multiple human cancer cell lines [4–7], and the key 
to understanding the molecular mechanisms underlying 
cancer and to improving cancer diagnostics, prognostics 
and treatment [1, 8, 9].
In this study we focused specifically on ChIP-seq-
based analysis of dynamically changing H3K4me3 and 
H3K27me3 enrichment in response to fluctuating oxygen 
levels. MCF7 cells were exposed to 8 and 24 h of hypoxia, 
and subsequently reoxygenated, serving as a model for 
such dynamic epigenetic effects occurring in response to 
reduced oxygen availability in solid tumors [10]. Analysis 
of a highly dynamic biological system, where the major-
ity of epigenetic markings and gene expression levels will 
be altered between physiologically distinct states, as well 
as display a large degree of heterogeneity across the cell 
population due to epigenetic selection and stochasticity, 
poses a number of challenges on data analysis.
First, the expected heterogeneity, i.e., the observation 
that the same region can harbor a specific epigenetic 
mark in some part of the cell population, while not in 
the other, results in (1) a quantitative range of ChIP-seq 
signals within a state and (2) quantitative differences 
between states. Although ChIP-seq data are tradition-
ally treated as dichotomous (i.e., present/not present), 
here quantitative data comparison is therefore a must. 
This requires normalization of the ChIP-seq data [11]. 
Most commonly, a scaling approach relative to the total 
number of aligned reads is applied, based on the predic-
tion that the number of differences between conditions is 
limited [12–14]. This assumption, however, does not hold 
here, as quantitative data comparison between highly 
variant states requires invariant measurement sets across 
all experimental conditions as a reference, such as an 
artificial spike-in [15–17], or biologically steadily marked 
H3K4me3/H3K27me3 regions (by analogy: steadily 
expressed genes in transcriptomic studies). However, 
a priori definition of regions with sustained epigenetic 
marking is challenging, as this depends on the biologi-
cal model as well as the studied histone modification 
[13]. To accommodate study-specific approaches [18], an 
unsupervised approach is required to identify and define 
epigenetically invariant genomic regions.
Second, although biological interpretation of ChIP-seq 
data by itself is legitimate [19–21], integration of tran-
scriptomics data is pivotal for a comprehensive biological 
interpretation [22]. We extrapolate from this observation 
to propose that transcriptomics data analysis is a require-
ment for biology-driven preprocessing of ChIP-seq data. 
Specifically, the invariant regions used for ChIP-seq data 
normalization should be defined in conjunction with 
transcriptomics data.
Considering the challenges presented by a highly vari-
ant biological system, we pursued the invariant-set para-
digm outlined above in a data-driven analysis approach 
combining genes with sustained expression and genomic 
regions with sustained H3K4me3 and H3K27me3 mark-
ings across all states. The approach enables quantitative 
data comparison for H3K4me3 and H3K27me3 ChIP-seq 
data and a comprehensive integrative analysis of epig-
enomics and transcriptomics data. The biological insights 
derived from the analysis are further corroborated a 




MCF7 cells were exposed to 8 or 24 h of hypoxia (0.02 % 
oxygen) and subsequently reoxygenated for 8  h (21  % 
oxygen) (see Methods section for details). Cells were har-
vested and processed for ChIP-seq and microarray-based 
expression analysis at 0, 8 and 24 h of hypoxia (referred 
to as t = 0, t = 8 and t = 24, respectively), and at 8 h of 
reoxygenation (referred to henceforth as t =+8).
Quantitative analysis of sustained and dynamic H3K27me3 
enrichment under fluctuating oxygen levels
To enable quantitative analysis, H3K27me3 datasets were 
normalized based on identification of regions with sus-
tained H3K27me3 enrichment between all samples ana-
lyzed. The cumulative area under the curve (AUC) for all 
peaks in all these regions was determined for each con-
dition, resulting in sample-specific scaling factors (see 
Methods section for details).
For H3K27me3, after normalization, a single cutoff 
value for all samples was set at the peak height above 
which the H3K27me3 data correlated with the ChIP-
seq data of CBX8, a known H3K27me3-binding protein 
under normoxic conditions (t  =  0) [23], corresponding 
to a normalized height of 5.0 on a log2 scale. For biologi-
cal interpretation analyses, we set the level of biologi-
cal significance at two times this background level (6.0 
on a log2 scale) and considered peaks below this value 
background noise (i.e., biologically irrelevant). To add 
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further biological validity to this threshold, we defined 
a set of 1137 genes whose expression levels were above 
the 95th percentile for all samples analyzed, i.e., consist-
ently highly expressed genes. Any repressive H3K27me3 
enrichment present in these genes were considered back-
ground noise, and indeed, the median enrichment of 
highly expressed genes H3K27me3 peaks was found to 
be below our previously calculated threshold (4.9 on log2 
scale).
For the dataset used to develop the protocol, regions 
with sustained epigenetic marking were found near cen-
tromeres and in intergenic regions. A number of regions 
with dynamically altered or sustained epigenetic marking 
were validated by conventional ChIP-PCR (Fig. 1): Oxy-
gen deprivation and/or reoxygenation clearly affected 
H3K27me3 enrichment at the APLN and OPRL1 loci, 
whereas the two indicated regions on chromosome 3 
remained relatively constant. The SLC9A5 locus shows an 
increase in response to 8 h of hypoxia, followed by a drop 
at 24 h of hypoxia and again an increase upon reoxygena-
tion. The ChIP-seq results suggest a slight increase in 
H3K27me3 enrichment around the TSS at the LOX locus, 
which is restored upon reoxygenation. In the ChIP-PCR 
results, only the drop in enrichment upon reoxygenation 
is reflected. The CCNA2 locus was used as a negative ref-
erence as it is known to be free of H3K27me3 marking 
[24].
Correlation analysis revealed a substantial overlap 
between peaks for each trimethyl histone modification 
under normoxic versus hypoxic conditions (Spearman ρ 
at 0 versus 24 h of hypoxia: 0.77 for H3K4me3, 0.60 for 
H3K27me3; p  <  0.05). These data indicated that preex-
istent (normoxic) H3K4me3 and H3K27me3 marking 
was generally retained under hypoxic conditions and 
that enrichment increased during hypoxia. Of relevance, 
these observations validated the invariant region nor-
malization strategy supporting the comparative histone 
H3K27me3 analysis. H3K4me3 enrichment (i.e., the 
relative amount of the genome associated with peaks) 
returned to the normal situation upon reoxygenation (ρ 
for normoxia versus reoxygenation: 0.82; p  <  0.05). In 
contrast, H3K27me3 enrichment showed poor correla-
tion between normoxia and reoxygenation (ρ  =  0.19; 
not significant), indicating that the original normoxic 
H3K27me3 distribution had not been restored at 8 h of 
reoxygenation.
Identification of genes with sustained and dynamic 
H3K4me3 enrichment under fluctuating oxygen levels
We and others have previously observed that most 
H3K4me3 enrichment is located over the transcrip-
tion start sites (TSSs) of genes. Using a set of 276 epi-
genetically and transcriptionally invariant genes, the 
enrichment of H3K4me3 surrounding in TSS (region 
defined as −1000  bp to +100  bp of the TSS [4]) was 
summed, yielding sample-specific scaling factors to 
which each peak in the dataset was scaled. A number of 
genes with dynamically altered or sustained expression 
were validated by conventional ChIP-PCR. Oxygen dep-
rivation and/or reoxygenation clearly affected H3K4me3 
enrichment at the ATP2A3, FOXF1 and IGFBP4 loci 
(Fig.  2), showing a gain in enrichment under hypoxia 
and a decrease upon reoxygenation, in both the ChIP-
seq and the ChIP-PCR results. Although the H3K4me3 
enrichment for CCNA2, DPM1 and NOL11 is relatively 
sustained in response to hypoxia and subsequent reoxy-
genation (Fig.  2), the ChIP-PCR results suggest a rela-
tively small change in H3K4me3 enrichment which is not 
reflected in the ChIP-seq results. A GO enrichment anal-
ysis on all 276 genes with sustained H3K4me3 enrich-
ment and high expression suggests that these loci, which 
encode factors involved in RNA binding, translation and 
protein transport and localization as main processes, are 
not subject to transcriptional regulation under fluctuat-
ing oxygen levels.
Hypoxia‑induced bivalency is associated with CpG‑rich 
regions near developmental genes
Since the data are normalized and the same threshold is 
applied across samples, we can reliably assess dynamics 
of H3K27me3 and H3K4me3 enrichment under hypoxia 
and subsequent reoxygenation. As illustrated in Fig.  3a, 
the enrichment of H3K4me3 in genes increases signifi-
cantly after 8  h (fold change (FC) of 1.88 compared to 
t = 0; p < 0.05) and 24 h of hypoxia (FC of 2.32 cf. t = 0; 
p < 0.05), with a slight drop upon reoxygenation (FC of 
1.51 cf. t = 0; p < 0.05). Interestingly, H3K27me3 enrich-
ment increases significantly after 8  h of hypoxia (FC of 
1.82 cf. t = 0; p < 0.05), then decreases at 24 h of hypoxia 
(FC of 1.43 cf. t = 0; p < 0.05) and then upon reoxygena-
tion drops to comparable levels as observed during nor-
moxia (fold change of 1.08 compared to t = 0; p < 0.05).
In addition to the dynamic changes observed for the 
individual trimethyl histone modifications, compara-
tive epigenomic analysis for H3K4me3 and H3K27me3 
suggested that in response to oxygen deprivation, the 
number of bivalently marked genes (i.e., H3K4me3 and 
H3K27me3) increased (results not shown). Bivalency in 
embryonic stem cells (ES cells) occurs at key develop-
mental control genes and coincides with genomic cyto-
sine-guanidine dinucleotide (CpG)-content (i.e., CpG 
islands) [25, 26]. To verify whether this applied to biva-
lent epigenetic marking in MCF7 cancer cells as well, the 
prevalence of bivalently marked genes was determined in 
high CpG-content promoter/enhancer regions (HCPs) 
versus intermediate and low CpG regions (ICP and LCP, 
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Fig. 1 Validation of sustained and dynamic H3K27me3 marking. Bioinformatic calling of enriched regions (gene tracks shown at left side for each 
locus) was validated by ChIP‑PCR (bar plots; shown at right side for each locus) for a number of representative epigenetic profiles. Data for all time points 
are shown: normoxia (0), hypoxia 8 h (8), hypoxia 24 h (24) and reoxygenation (+8). Two regions used for normalization on chromosome 3 show sus‑
tained H3K27me3 enrichment (left panels); the CCNA2 locus is known to be free of H3K27me3 marking [24] (bottom panel); OPRL1, SLC9A5, APLN and LOX 
for genes that show dynamic modulation of H3K27me3 marking in relation to changes in oxygen pressure; gene‑specific ChIP‑PCR analyses are part of 
a biological study published elsewhere [10]. Diamond symbol indicates direction of transcription, black triangle indicates approximate position of primer 
set used for validation, and star symbol indicates a significant difference compared to t = 0 (i.e., normoxia; p < 0.05, Wilcoxon signed‑rank test)
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Fig. 2 Validation of sustained and dynamic H3K4me3 marking. Bioinformatic calling of enriched regions (gene tracks shown at left side for each 
locus) was validated by ChIP‑PCR (bar plots; shown at right side for each locus) for a number of representative epigenetic profiles. Data for all time 
points are shown: normoxia (0), hypoxia 8 h (8), hypoxia 24 h (24) and reoxygenation (+8). CCNA2, DPM1 and NOL11 for genes that show sustained 
H3K4me3 marking in relation to changes in oxygen pressure (left panels); ATP2A3, FOXF1 and IGFBP4 for genes that show dynamic modulation of 
H3K4me3 marking in relation to changes in oxygen pressure (right panels); gene‑specific ChIP‑PCR analyses are part of a biological study published 
elsewhere [10]. Diamond symbol indicates direction of transcription, black triangle indicates approximate position of primer set used for validation, 
and star symbol indicates a significant difference compared to t = 0 (i.e., normoxia; p < 0.05, Wilcoxon signed‑rank test)
Page 6 of 11Adriaens et al. Epigenetics & Chromatin  (2016) 9:48 
respectively). H3K4me3 preferentially localized to HCP; 
5373 HCP, 2963 ICP and 1373 LCP promoters carried 
H3K4me3 marking at normoxia, corresponding to 73 % 
of charted HCPs, 58 % of ICPs and 13 % of LCPs, respec-
tively (Fig. 3b). Bivalently marked genes showed a highly 
similar distribution pattern: 428 HCP, 238 ICP and 155 
LCP promoters were positive for both trimethyl histone 
modifications in control cells (t = 0). Relatively few pro-
moters showed H3K27me3 marking, consistent with the 
relative H3K27me3 enrichment over gene bodies or at 
the TSS. H3K27me3/promoter distribution was oppo-
site of that of H3K4me3: 296 HCP, 252 ICP and 599 LCP 
promoters were enriched for H3K27me3 (Fig. 3b). Addi-
tionally, we see a high correspondence between bivalent 
marking in ES cells and CpG content, transcription fac-
tor (TF) binding sites and transposon exclusion zones 
(TEZs); using data from [25, 27] (Fig. 3c).
Discussion
We have shown that applying a data-driven analy-
sis approach using invariant genes and epigenetically 
marked regions allows for genome-wide, quantitative 
data comparison for H3K4me3 and H3K27me3 ChIP-
seq data across highly variant experimental conditions. 
Although opting for data-driven approaches may result 
in analytical parameter use that may not be applicable to 
other studies [14], the concepts we apply are. As reported 
by others [18], one needs to be aware of the biology 
underlying the data to choose a correct data analysis 
approach, arguably regardless of the genericity of that 
choice.
A robust normalization strategy analogous to our 
approach is spike-in normalization [15–17]. Both meth-
ods use a set of common references for data normaliza-
tion and apply an identical scaling approach based on 
some cumulative value for these common references 
[16]. Additionally, others have acknowledged that in the 
absence of spike-in controls, regions of the genome that 
have stable quantifiable occupancy through all experi-
mental conditions are appropriate to use as an alterna-
tive for ChIP-seq data normalization [13, 16]. Here, due 
to our dataset lacking spike-in controls, we followed this 
strategy and, through qPCR validation, demonstrated it 
to indeed yield robust results. ChIP-seq datasets with and 
without spike-in controls are both widely generated and 
available in online repositories, and hence, the choice to 
apply either approach to a specific dataset would depend 
solely on the presence or absence of such controls.
Regions with stable enrichment across experimental 
conditions are primarily located around centromeres. 
Centromere regions are known for containing a large 
number of repeats. Repeat region reads will inevitably 
be mapped to such regions, regardless of their origin, 
meaning that the high enrichment within these regions 
might reflect a technical artifact rather than biology. 
Paired-end sequencing combined with filtering out of 
reads with ambiguous genomic alignment, as done here, 
should, however, adequately prevent this from occur-
ring. Also, it has been observed previously that cen-
tromeres are heavily enriched for H3K27me3 and other 
histone modifications [28–31]. ChIP-PCR validation 
confirmed regions with sustained and dynamic enrich-
ment identified in the ChIP-seq results. Disparities 
between the PCR and sequencing results, where small 
changes in enrichment picked up in the former are not 
reflected in the latter, suggest that mostly large changes 
in histone trimethylation are picked up in the ChIP-seq 
analysis. Increasing the sample size could enable a more 
sensitive analysis of the hypoxia-induced epigenetic 
changes.
Although the overall number of H3K4me3-, 
H3K27me3- or H3K4me3/H3K27me3-enriched genes 
increased in response to hypoxia, their relative associa-
tion to HCP, ICP and LCP was sustained (Fig.  3b). We 
and others found a clear increase of bivalent marking 
at CpG-rich genomic regions [4]. CpG islands are usu-
ally hypomethylated (at the DNA level), but instead are 
marked by trimethylation of histone 3 lysine 4 or lysine 
27 [4, 32]; conversely, bivalent domains highly correlate 
with the presence of CpG islands and may reflect a com-
petition between PRC recruitment (silencing) and tran-
scriptional activation [33]. Key developmental control 
loci (genes) typically carry numerous TF binding sites, 
often display high CpG dinucleotide-content and are 
typically relative transposon free (localize at TEZ). We 
observed an overlap between the bivalently marked genes 
in our study and those from a previously published study 
in ES cells (Fig. 3c; [25, 27]). Thus, congruent with obser-
vations in ES cells, hypoxia-induced bivalency in MCF7 
cells also occurs at loci encoding factors that control 
developmental processes, and the association of biva-
lent marking and CpG-rich regions holds for hypoxia-
induced bivalency in MCF7 as well.
Conclusions
In conclusion, we here demonstrated how a data-driven 
approach using invariant genes and occupied regions 
enables genome-wide, quantitative data comparison for 
H3K4me3 and H3K27me3 ChIP-seq data, integrated 
with whole-genome transcriptomics in a dynamic biolog-
ical system. Results are corroborated by published data 
and current insights regarding epigenetic regulation. In 
silico-identified invariant genomic regions, in addition to 
dynamic regions, were confirmed through normal ChIP-
PCR in vitro, showing that the approach based on data-
set-specific invariant regions enables robust analysis of 
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Fig. 3 Genomic element enrichment of genes with acquired bivalency under hypoxia. a Both H3K4me3 enrichment and H3K27me3 enrichment 
increase in genes in response to hypoxia, with a decrease upon reoxygenation which is most pronounced for the H3K27me3 mark. The total AUC 
(log2‑transformed) of all ChIP‑seq peaks in a gene is represented on the y axis (mean over all genes and standard error are shown). Star symbol 
indicates a significant difference compared to t = 0 (i.e., normoxia; p < 0.05, Wilcoxon signed‑rank test). b Distribution of H3K4me3‑ and H3K27me3‑
enriched promoters with (top) high CpG, (middle) intermediate and (bottom) low CpG‑content. c Overlap of bivalent genes in this study with 
bivalently marked genes in embryonal stem cells (ES cells [27]), transcription factor (TF [25]; in gray) genes, genes containing promoter CpG islands 
(CpG [25]; in white) and genes whose TSS coincides with transposon exclusion zones (TEZ [25]; in black)
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highly dynamic changes in epigenetic marking and gene 
expression between physiologically distinct states.
Methods
Cell culture and experimental conditions
MCF7 (human mammary adenocarcinoma) cells were 
maintained under standardized culturing conditions 
(37 °C, 5 % CO2, 100 % humidity). For hypoxic exposure, 
cells were transferred to a MACS VA500 microaerophilic 
workstation (Don Whitley Scientific, Shipley, UK) for 
8 (acute hypoxia) or 24  h (chronic hypoxia) at <0.02  % 
O2 (5  % H2, 5  % CO2, residual N2). Reoxygenation was 
achieved by transferring cells to the regular tissue culture 
conditions (i.e., ambient oxygen levels). Throughout the 
manuscript, the following definitions are used for each 
state: normoxia (t = 0), hypoxia 8 h (t = 8), hypoxia 24 h 
(t = 24) and reoxygenation (t =+8).
Gene expression microarray processing and analysis
RNA for microarray application was isolated using RNe-
asy mini kit (Qiagen, Hilden, Germany) according to 
manufacturer’s protocol. Isolations were performed in 
triplicate. Total RNA samples were analyzed using the 
Affymetrix expression array platform (Affymetrix Gene 
Chip 1.0 ST). After scanning, data preprocessing and 
data analysis were done with R (http://www.R-project.
org; version 2.15) using Bioconductor (http://www.bio-
conductor.org; version 2.11). Data were background-cor-
rected using gcRMA [34]. Two common assumptions for 
gene expression microarray normalization are that the 
majority of genes is not differentially expressed between 
conditions (e.g., from t  =  0 to t  =  8) and that there is 
approximately the same amount of up- and down-reg-
ulated genes. Those assumptions did not hold for this 
study, and hence, a data-driven GRSN rank-invariant 
normalization [35] was used. Updated ENSEMBL-based 
probe set annotation was used from Brain Array (http://
brainarray.mbni.med.umich.edu/brainarray/). All genes 
which were not represented on the microarray were not 
included for further analysis. Functional enrichment of 
associated genes was performed using the topGO pack-
age in R, using the parent–child algorithm [36] with a 
minimum node-size of 5.
Chromatin immunoprecipitation (ChIP) assays, qPCR 
and deep sequencing
Details of the ChIP procedure and ChIP-grade antisera 
H3K4me3 and H3K27me3 antisera have been described 
elsewhere [10]; the CBX8 ChIP-grade antiserum was 
a courtesy of Klaus Hansen (BRIC, Copenhagen, DK) 
[23]. Input and ChIP samples were sequenced using 
the 36-bp paired-end protocol on the Illumina Genome 
Analyser IIx (GAIIx). In order to obtain sufficient 
sequencing depth, additional lanes were sequenced when 
necessary.  All data obtained from each individual sam-
ple were pooled. Paired-end sequencing was chosen as it 
provides two connected DNA end-tags, enabling reliable 
identification of enriched regions. In addition, paired-
end sequencing is more powerful in identifying enrich-
ment in repeat regions, such as satellite DNA regions 
near centromeres, and several histone modifications are 
known to be associated with such regions and as such are 
of biological interest [28, 37].
Alignment of ChIP‑seq reads and identification of enriched 
regions
Image processing and base calling were performed using 
Illumina software tools provided by the manufacturer. 
Subsequent paired-end genome alignment was per-
formed using Novoalign with Human Genome 18 (HG18) 
used as a reference genome. Only uniquely aligned reads 
were used for further analysis. To remove PCR artifacts, 
all data were collapsed prior to peak calling. To identify 
enriched regions in the ChIP samples relative to the input 
control, the peak caller FindPeaks (version 4.0) was used. 
Although alignment tools in general produce comparable 
results, FindPeaks [38] is most sensitive in distinguishing 
enrichment [39] compared to PeakSeq [40], USeq [41] 
and MACS [42].
Identification of enriched regions requires a null dis-
tribution [43], ideally in the form of a sequenced input 
sample which allows for proper correction of background 
anomalies, such as amplified regions and variability in 
shearing of DNA [44]. As we had input samples available, 
they were used in the enrichment finding process.
For H3K4me3 peak detection, the default settings were 
used. H3K27me3 enrichment tends to spread and cover 
an entire locus, a phenomenon termed “blanketing” [4]. 
This results in data comprising spread-out enrichment 
signals covering large genomic regions [4, 24, 45] instead 
of sharp peaks. In order to successfully identify such 
broad regions of enrichment, while still retaining the 
advantages of using an input DNA sample as a reference, 
the expected sequence distribution setting in the Find-
Peaks algorithm was adjusted for H3K27me3, by setting 
it twice as large as the default settings used for H3K4me. 
This setting was chosen as we observed that the signal 
distribution around the TSS for H3K27me3 was approxi-
mately twice as broad as the TSS signal of H3K4me3 
(Additional file 1: Figure S1).
H3K27me3 and H3K4me3 ChIP‑seq data normalization, 
ChIP‑PCR validation
For H3K27me3 data normalization, an unsuper-
vised approach was applied to identify regions of sus-
tained high enrichment under normoxic and hypoxic 
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conditions. Sustained high enrichment represents 
regions that have a specific histone marking across the 
entire population of cells, i.e., maximum enrichment 
which is unable to increase further. First, WIG files con-
taining peak data were imported into R. All peaks were 
summarized based on their mean location and maximum 
height. Next, for each sample (four experimental con-
ditions; i.e., 0, 8 and 24  h of hypoxia and 8  h of reoxy-
genation) an ACME data object was created [43], and the 
ACME algorithm was run using a window size of 20 kb 
and a cutoff of 0.90 corresponding the 90th percentile of 
all peak heights in a sample. Briefly, based on the cutoff 
peaks are dichotomized into two classes, positive and 
negative. Using a sliding window approach, each genomic 
window is tested for having a significantly higher num-
ber of observed positive peaks than expected using a Chi-
square test. The window size of 20,000 bp was chosen as 
it is larger than the observed average peak width, while 
being small enough to lead to a reasonable specificity. 
Upon completion of the ACME analysis, only regions 
with a Chi-square test p value smaller than 1 × 10−5 in 
all samples/conditions were considered. The cumulative 
area under the curve (AUC) for these regions was deter-
mined for each sample (four time points). By dividing the 
four AUC values by the smallest value sample-specific 
scaling factors were obtained to which all the peaks were 
scaled.
For H3K4me3 data normalization, we postulated that 
genes with invariant expression should have invariant 
H3K4me3 enrichment. Consistent with a previous report 
[46] that the ratio of H3K4me3 and H3K27me3 enrich-
ment correlates with the degree of gene transcription, we 
see a similar trend at t = 0 (normoxia) (Additional file 1: 
Figure S2). The robust rank-invariant GRSN normaliza-
tion application for transcriptomics data allowed us to 
identify genes with sustained expression across condi-
tions by using the coefficient of variance (CV). Combined 
with our observation that within our study H3K27me3 
modulations appear to have little effect on the differen-
tial expression of genes [10], we assumed that H3K4me3 
enrichment at the TSS (region defined as −1000 to 
+100 of TSS [4]) of genes with sustained expression to 
be invariant. Hence, of all genes with a CV <0.10 and 
expressed above background level [10] the AUC of all 
present H3K4me3 peaks in the TSS region (TSS ± 1 kb) 
was summed. Peaks were subsequently scaled using scal-
ing factors calculated relative to the smallest AUC sum 
among the samples.
Primers sets used for ChIP-PCR-based valida-
tion have been published elsewhere [10]; primer sets 
used for validation of stable regions were: >ID:chr3.1 
|CH:3|1|64757658|64764909: GAGGCAGGGCTATGC 
GATAGT (forward) and GTAGGGCGTAAGCAGGGA 
CAC (reverse); >ID:chr3.2|CH:3|1|64843889|64850613: 
TCAATAACTAGGCCACATTGGATC (forward) and 
ATTGGTACAAGACCTCCTGGCTT (reverse).
Linking of microarray gene expression data and H3K27me3 
and H3K4me3 ChIP‑seq data at gene level
 The microarray gene expression data and the 
H3K27me3 and H3K4me3 enrichment ChIP-seq data 
were integrated using the latest ENSEMBL genome 
annotation. For the identification of H3K27me3- and/
or H3K4me3-enriched genes, we defined a gene as 
the region between its 5′ (most upstream TSS) and 
3′ (last exon) end plus 5  kb regulatory regions up and 
downstream, respectively. A gene was called enriched 
or marked when there was at least one ChIP-seq peak 
above background level present within this region 
as determined by the enrichment finding procedure. 
Gene-based enrichment levels are the total AUC of all 
peaks present in the gene region.
Statistical analyses
All differences in H3K4me3 and H3K27me3 enrich-
ment levels, for both the standard ChIP-PCR results and 
ChIP-sequencing results, were tested statistically by the 
Wilcoxon signed-rank test. p values for Spearman corre-
lations were computed via the asymptotic t approxima-
tion. In all cases, a nominal p value smaller than 0.05 was 
considered statistically significant.
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